Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-05-30 @ 1:57 PM
Study NCT ID:
NCT07022834
Status:
RECRUITING
Last Update Posted:
2025-06-15
First Post:
2025-06-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
Sponsor:
West China Second University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WCSH-LCH-2025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None